Intelligent nanovesicle for remodeling tumor microenvironment and circulating tumor chemoimmunotherapy amplification
Journal of Nanobiotechnology · 16.05.2024 · 22 (1)
DOI: 10.1186/s12951-024-02467-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Nanobiotechnology, online erschienen am 16.05.2024. Verfasst von Manxiu Huai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200092, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Fluorouracil, Immunotherapy, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Imperceptible examination and unideal treatment effect are still intractable difficulties for the clinical treatment of pancreatic ductal adenocarcinoma (PDAC). At present, despite 5-fluorouracil (5-FU), as a clinical first-line FOLFIRINOX chemo-drug, has achieved significant therapeutic effects. Nevertheless, these unavoidable factors such as low solubility, lack of biological specificity and easy to induce immunosuppressive surroundings formation, severely limit their treatment in PDAC. As an important source of energy for many tumor cells, tryptophan (Trp), is easily degraded to kynurenine (Kyn) by indolamine 2,3- dioxygenase 1 (IDO1), which activates the axis of Kyn-AHR to form special suppressive immune microenvironment that promotes tumor growth and metastasis. However, our research findings that 5-FU can induce effectively immunogenic cell death (ICD) to further treat tumor by activating immune systems, while the secretion of interferon-γ (IFN-γ) re-induce the Kyn-AHR axis activation, leading to poor treatment efficiency. Therefore, a metal matrix protease-2 (MMP-2) and endogenous GSH dual-responsive liposomal-based nanovesicle, co-loading with 5-FU (anti-cancer drug) and NLG919 (IDO1 inhibitor), was constructed (named as ENP919@5-FU). The multifunctional ENP919@5-FU can effectively reshape the tumor immunosuppression microenvironment to enhance the effect of chemoimmunotherapy, thereby effectively inhibiting cancer growth. Mechanistically, PDAC with high expression of MMP-2 will propel the as-prepared nanovesicle to dwell in tumor region via shedding PEG on the nanovesicle surface, effectively enhancing tumor uptake. Subsequently, the S-S bond containing nanovesicle was cut via high endogenous GSH, leading to the continued release of 5-FU and NLG919, thereby enabling circulating chemoimmunotherapy to effectively cause tumor ablation. Moreover, the combination of ENP919@5-FU and PD-L1 antibody (αPD-L1) showed a synergistic anti-tumor effect on the PDAC model with abdominal cavity metastasis. Collectively, ENP919@5-FU nanovesicle, as a PDAC treatment strategy, showed excellent antitumor efficacy by remodeling tumor microenvironment to circulate tumor chemoimmunotherapy amplification, which has promising potential in a precision medicine approach.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200092, China.
- Nano Science and Technology Institute, University of Science and Technology of China, Suzhou, 215123, China.
- Department of Nuclear Medicine, Shanghai Changhai Hospital, Shanghai, 200433, China.
- Department of Gastroenterology Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200092, China. zhangyi02@xinhuamed.com.cn.
- Department of Gastroenterology Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200092, China. xuleiming@xinhuamed.com.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Huai, M., Wang, Y., Li, J., Pan, J., Sun, F., Zhang, F., Zhang, Y., & Xu, L. (2024). Intelligent nanovesicle for remodeling tumor microenvironment and circulating tumor chemoimmunotherapy amplification. Journal of Nanobiotechnology, 22(1). https://doi.org/10.1186/s12951-024-02467-8
Vancouver
Huai M, Wang Y, Li J, Pan J, Sun F, Zhang F, et al. Intelligent nanovesicle for remodeling tumor microenvironment and circulating tumor chemoimmunotherapy amplification. Journal of Nanobiotechnology. 2024;22(1). doi:10.1186/s12951-024-02467-8
BibTeX
@article{Huai2024,
author = {Huai, Manxiu and Wang, Yingjie and Li, Junhao and Pan, Jiaxing and Sun, Fang and Zhang, Feiyu and Zhang, Yi and Xu, Leiming},
title = {Intelligent nanovesicle for remodeling tumor microenvironment and circulating tumor chemoimmunotherapy amplification},
journal = {Journal of Nanobiotechnology},
year = {2024},
volume = {22},
number = {1},
doi = {10.1186/s12951-024-02467-8}
}
EUVIMED